Salivary DNA Methylation as an Epigenetic Biomarker for Head and Neck Cancer. Part II: A Cancer Risk Meta-Analysis

Salivary DNA Methylation as an Epigenetic Biomarker for Head and Neck Cancer. Part II: A Cancer Risk Meta-Analysis

Aberrant methylation of tumor suppressor genes has been reported as an important epigenetic silencer in head and neck cancer (HNC) pathogenesis. Here, we performed a comprehensive meta-analysis to evaluate the overall and specific impact of salivary gene promoter methylation on HNC risk. The methodo...

Full description

Bibliographic Details
Main Authors: Óscar Rapado-González, Cristina Martínez-Reglero, Ángel Salgado-Barreira, María Arminda Santos, Rafael López-López, Ángel Díaz-Lagares, María Mercedes Suárez-Cunqueiro
Format: Article
Language:English
Published: MDPI AG 2021-06-01
Series:Journal of Personalized Medicine
Subjects:
DNA methylation
epigenetics
head and neck cancer
saliva
biomarkers
liquid biopsy
Online Access:https://www.mdpi.com/2075-4426/11/7/606

Internet

https://www.mdpi.com/2075-4426/11/7/606

Similar Items